Donald School Journal of Ultrasound in Obstetrics and Gynecology

Register      Login

VOLUME 3 , ISSUE 4 ( October-December, 2009 ) > List of Articles


3-D and Power Doppler Ultrasound in Translational Research

Lakshmanaswamy Rajkumar

Keywords : Mammary gland tumors,animal models,3-D ultrasound imaging,color Doppler imaging,3-D power Doppler imaging

Citation Information : Rajkumar L. 3-D and Power Doppler Ultrasound in Translational Research. Donald School J Ultrasound Obstet Gynecol 2009; 3 (4):81-84.

DOI: 10.5005/jp-journals-10009-1043

License: CC BY-NC 4.0

Published Online: 01-12-2010

Copyright Statement:  Copyright © 2009; The Author(s).


At Texas Tech University Health Sciences Center in El Paso we have developed an animal model to study mammary carcinogenesis and neovascularization. Seven-week-old female Sprague Dawley rats are injected with N-methyl-N-nitrosourea (MNU) intraperitoneally at a concentration of 50 mg/kg bodyweight. The rats are palpated twice a week for development of mammary gland tumors. On the appearance of the first palpable tumor, the animals are divided into the groups treated with aromatase inhibitor, ethanolic neem leaf extract and control group, receiving vehicle treatment. Using a high-resolution 16 MHz linear array transducer mammary glands are imaged before and every two weeks following the introduction of the therapy. 3-D US coupled with 3-D power Doppler imaging is used for evaluation of the volume and vascularity of the mammary gland lesions. Pulsatility and resistance index and vascularity, flow and vascularity flow indices are evaluated longitudinally. Our preliminary data indicate that 2-D and 3-D power Doppler ultrasound may be efficiently used for evaluation of the mammary gland tumor volumes and vascularity. 2-D and 3-D power Doppler ultrasound may also be used for evaluation of the response of mammary gland tumors to different lines of medication therapy.

PDF Share
  1. Suppression of 7,12-dimethylbenz (a) anthraceneinduced mammary carcinogenesis by preinitiation treatment of rats with beta-naphthoflavone coincides with decreased levels of the carcinogen-derived DNA adducts in the mammary gland. Cancer Detect Prev 2005;29(4):338-47.
  2. Application of proteomic technologies to tumor analysis. Pharmacogenomics 2004;5(8):1129-37.
  3. Inducible silencing of KILLER/DR5 in vivo promotes bioluminescent colon tumor xenograft growth and confers resistance to chemotherapeutic agent 5-fluorouracil. Cancer Res Sep 2004;15;64(18):6666-72.
  4. Bioluminescent molecular imaging of endogenous and exogenous p53-mediated transcription in vitro and in vivo using an HCT116 human colon carcinoma xenograft model. Cancer Biol Ther 2003;2(2):196-202.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.